HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David R Cornblath Selected Research

Hizentra

1/2022Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy.
1/2020Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review.
1/2019Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study.
1/2019Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.
1/2019Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.
1/2018IgPro20, the Polyneuropathy and Treatment with Hizentra® study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG.
1/2018Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
1/2016Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David R Cornblath Research Topics

Disease

18Polyneuropathies (Polyneuropathy)
07/2023 - 10/2006
16Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
12/2023 - 12/2014
8Peripheral Nervous System Diseases (PNS Diseases)
07/2023 - 03/2008
8Guillain-Barre Syndrome
10/2021 - 11/2005
7Pain (Aches)
12/2023 - 01/2017
4Miller Fisher Syndrome (Fisher Syndrome)
12/2023 - 01/2019
3Infections
12/2023 - 06/2009
2Fatigue
12/2023 - 12/2023
2Neuralgia (Stump Neuralgia)
11/2021 - 01/2021
2Sudden Infant Death (SID)
01/2021 - 12/2018
2Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2021 - 06/2004
2Neoplasms (Cancer)
01/2017 - 12/2010
2Monoclonal Gammopathy of Undetermined Significance
09/2015 - 12/2014
1Osteoarthritis
07/2023
1Paresthesia (Dysesthesia)
07/2023
1Hypesthesia (Numbness)
07/2023
1Mononeuropathies (Mononeuritis Multiplex)
07/2023
1Muscle Weakness
01/2023
1Ataxia (Dyssynergia)
01/2023
1Dermatitis
01/2023
1Hodgkin Disease (Hodgkin's Disease)
01/2021
1Clinical Deterioration
01/2019
1Parkinson Disease (Parkinson's Disease)
05/2013
1Multiple Sclerosis
05/2012
1Seizures (Absence Seizure)
05/2012
1Hypersensitivity (Allergy)
09/2010
1Immune System Diseases (Immune Disorders)
09/2010
1Demyelinating Diseases (Demyelinating Disease)
06/2009
1Experimental Autoimmune Neuritis
11/2005
1Rhabdomyolysis
11/2005
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2005
1Respiratory Insufficiency (Respiratory Failure)
08/2005
1Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease)
06/2004
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2004

Drug/Important Bio-Agent (IBA)

18Intravenous Immunoglobulins (IVIG)FDA Link
12/2023 - 11/2005
8HizentraIBA
01/2022 - 01/2016
8Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2016
6Adrenal Cortex Hormones (Corticosteroids)IBA
12/2023 - 11/2005
4AntibodiesIBA
12/2023 - 11/2005
4Immunoglobulin M (IgM)IBA
01/2023 - 06/2013
3GangliosidesIBA
12/2023 - 11/2005
2Carbamazepine (Tegretol)FDA LinkGeneric
12/2023 - 12/2023
2Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
12/2023 - 12/2023
2Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2023
2Immunosuppressive Agents (Immunosuppressants)IBA
11/2021 - 01/2021
2Immunoglobulin G (IgG)IBA
01/2020 - 01/2018
2Rituximab (Mabthera)FDA Link
06/2013 - 09/2010
2Amantadine (Aman)FDA LinkGeneric
06/2009 - 11/2005
1Nerve Growth Factor (NGF)IBA
07/2023
1tanezumabIBA
07/2023
1Myelin-Associated GlycoproteinIBA
01/2023
1antineoplaston A10 (A 10)IBA
01/2023
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2021
1COVID-19 VaccinesIBA
01/2021
1Proline (L-Proline)FDA Link
01/2018
1PanzygaIBA
01/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
05/2013
1Carbidopa (Lodosyn)FDA LinkGeneric
05/2013
1Levodopa (L Dopa)FDA LinkGeneric
05/2013
1TabletsIBA
05/2012
14-Aminopyridine (4 Aminopyridine)FDA Link
05/2012
12-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
12/2010
1Diphenhydramine (Benadryl)FDA LinkGeneric
09/2010
1Monoclonal AntibodiesIBA
09/2010
1Acetaminophen (Paracetamol)FDA LinkGeneric
09/2010
1AntigensIBA
09/2010
1CytokinesIBA
06/2009
1Bortezomib (Velcade)FDA Link
12/2008
1Proteasome InhibitorsIBA
12/2008
1Thalidomide (Thalomid)FDA Link
12/2008
1Myelin ProteinsIBA
11/2005
1Peptides (Polypeptides)IBA
11/2005
1MyoglobinIBA
11/2005
1Illicit Drugs (Recreational Drugs)IBA
11/2005
1Heparin (Liquaemin)FDA LinkGeneric
08/2005
1Myelin P0 Protein (Myelin Protein Zero)IBA
06/2004
1RNA Helicases (RNA Helicase)IBA
06/2004
1DNA (Deoxyribonucleic Acid)IBA
06/2004

Therapy/Procedure

7Therapeutics
01/2022 - 03/2008
4Plasma Exchange
11/2021 - 11/2005
4Drug Therapy (Chemotherapy)
01/2017 - 12/2010
1Immunotherapy
01/2019
1Drug Tapering
01/2018
1Combination Drug Therapy (Combination Chemotherapy)
12/2008
1Surgical Decompression
02/2007
1Highly Active Antiretroviral Therapy (HAART)
10/2006
1Tracheostomy
08/2005